PHLT Earnings

PHLT reported its earnings on 2025-08-07, showcasing a revenue of 37.80M against an estimate of 31.12M, resulting in a 21.47% surprise. The EPS was 0.06, surpassing the expected -0.03 by 300% . The stock experienced a -0.13% price change on the earnings day and a -0.26% change over the next five days, reflecting market reactions to the results.

Following PHLT's earnings announcement on 2025-08-07, the stock price moved by -0.13% on the day of the release. Over the subsequent five days, it saw a -0.26% change. Historically, PHLT's stock price tends to shift by an average of -11.98% in the 10 days leading up to earnings and +11.17% in the 10 days following, providing insight into potential market.

For , analysts estimate PHLT’s annual revenue to reach , while the EPS is projected at . These estimates reflect recent revisions, with revenue estimates revised Revenue No Change by 0% and EPS estimates No Change by 0% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between PHLT's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were No Change by 0%, while EPS estimates moved No Change by 0% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, PHLT's stock price typically moves by -11.98% in the 10 days before its earnings and +11.17% in the 10 days after. For the upcoming earnings, analysts expect an EPS of and revenue of .

The earnings call indicates a positive sentiment with increased revenue and adjusted EBITDA guidance, strong revenue growth, and positive cash flow. While there are risks like regulatory issues and competitive pressures, the company's strategic initiatives, such as Project Turing and New York State Medicaid RAC implementation, are expected to drive efficiency and revenue. The lack of a share repurchase program is a slight negative, but overall, the positive outlook and improved financial metrics suggest a stock price increase in the 2% to 8% range.